上皮性卵巢癌初诊时合并静脉血栓栓塞:围手术期结局与生存分析
回顾性分析2003年1月2日至2011年12月30日接受初次手术的上皮性卵巢癌患者843例,其中817例(第1组)诊断时无静脉血栓栓塞,26例(第2组)术前30天内发生静脉血栓栓塞并放置下腔静脉滤器。第2组体能状态更差、白蛋白更低、透明细胞组织学更多见,两组围手术期结局相似,总生存差异未达统计学显著(校正HR 1.39,95%CI 0.85-2.29,p=0.19)。
要点
- 初诊时合并静脉血栓栓塞并放置下腔静脉滤器的上皮性卵巢癌患者总生存更差但未达统计学显著。
- 两组围手术期结局相似,术后90天内死亡率第1组6.4% vs 第2组11.5%(p=0.24)。
- 合并静脉血栓栓塞者体能状态更差、白蛋白更低、透明细胞组织学更多见。
核心结论
- 初诊时诊断静脉血栓栓塞的上皮性卵巢癌患者结局较差,可能反映更具侵袭性的肿瘤生物学、静脉血栓栓塞后整体健康状况更差或静脉血栓栓塞导致的生存更差。
- 作者认为在合并静脉血栓栓塞的情况下必须仔细选择手术患者。
研究设计与样本
- 回顾性队列研究,纳入2003年1月2日至2011年12月30日接受初次手术的上皮性卵巢癌患者843例。
- 第1组817例诊断时无静脉血栓栓塞,第2组26例术前30天内发生静脉血栓栓塞并放置下腔静脉滤器。
- 采用Cox比例风险模型评估与总生存的关联。
主要发现
- 第2组体能状态更差、白蛋白更低、透明细胞组织学更多见。
- 两组围手术期结局相似。
- 术后90天内死亡率第1组6.4% vs 第2组11.5%(p=0.24)。
- 中位总生存第1组56.6个月 vs 第2组25.7个月,校正HR 1.39(95%CI 0.85-2.29,p=0.19),未达统计学显著。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare outcomes among women with epithelial ovarian cancer (EOC) undergoing primary surgery who present without venous thromboembolism (VTE) versus with VTE and placement of inferior vena cava (IVC) filter. METHODS: Women who underwent primary surgery for EOC between 1/2/2003 and 12/30/2011 were identified. Patient characteristics were retrospectively abstracted, including diagnosis of VTE within 30days prior to surgery and placement of IVC filter. Associations with overall survival (OS) were evaluated using Cox proportional hazards models. RESULTS: A total of 843 patients met inclusion criteria; 817 patients (Group 1) did not have VTE at the time of EOC diagnosis and 26 patients (Group 2) had a VTE and IVC placement within 30days prior to surgery. Group 2 had worse performance status, lower albumin, and more likely to have clear cell histology. Groups 1 and 2 were similar in terms of perioperative outcomes. Mortality within 90days of surgery was 6.4% in Group 1 versus 11.5% in Group 2 (p=0.24). Although median OS for group 1 was much higher than group 2, 56.6m versus 25.7m, in this cohort this difference did not reach statistical significance (adjusted HR 1.39, 95% CI 0.85-2.29, p=0.19). CONCLUSIONS: Patients with VTE diagnosed at the time of EOC diagnosis have poor outcomes. This may reflect more aggressive tumor biology, worse overall health of the patient following VTE, or may reflect worse survival secondary to the VTE. Patients must be carefully selected for surgery in the setting of VTE.
引用
- Kumar A, Hurtt CC, Cliby WA, et al. Concomitant venous thromboembolism at the time of primary EOC diagnosis: Perioperative outcomes and survival analyses. Gynecol Oncol. 2017. PMID: 28947173. doi:10.1016/j.ygyno.2017.09.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。